Ignite Creation Date:
2024-05-06 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03644771
Status:
UNKNOWN
Last Update Posted:
2020-02-05
First Post:
2018-08-22
Brief Title:
Experience With HP Acthar Gel Treatment of Patients With Nephrotic SyndromeProteinuria Due to Various Etiologies and Its Effect on Podocyte Function
Sponsor:
Organization:
Greater Boston Medical Associates
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
one red top tube of blood per month one 50cc urine container per month
Enrollment Count:
40
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 50481 |
Who Masked List: